Work

A Multicenter, Randomized, Open-Label Trial Evaluating Deferasirox Compared with Deferoxamine for the Removal of Cardiac Iron in Patients with β-Thalassemia Major and Iron Overload (CORDELIA).

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.2124.2124

Authors: Dudley J Pennell, John B Porter, Antonio Piga, Yongrong Lai, Amal El-Beshlawy, Khawla Beloul, Mohsen Elalfy, Akif Yesilipek, Yurdanur Kilinç, Tomasz Lawniczek, Dany Habr, Marianne Weisskopf, Yiyun Zhang, Yesim Aydinok

Institutions: Royal Brompton Hospital, University College London, University of Turin, First Affiliated Hospital of GuangXi Medical University, Cairo University, Latifa Hospital, Ain Shams University, Akdeniz University, Cukurova University, Novartis (Switzerland), Ege Üniversitesi Tıp Fakültesi Hastanesi

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2185955564

FWCI: 0.722

Cites:

Cited by: 9

Related to: 10